CDKN2B antibody (Cy7)
Quick Overview for CDKN2B antibody (Cy7) (ABIN706172)
Target
See all CDKN2B AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Specificity
- Excitation / Emission Wavelengths: 743nm/767nm
-
Cross-Reactivity
- Rat (Rattus), Chicken, Dog (Canine), Cow (Bovine)
-
Purification
- purified by Protein A
-
Immunogen
- KLH conjugated synthetic peptide derived from human CDKN2B
-
Isotype
- IgG
-
-
-
-
Application Notes
-
IF(IHC-P)(1:100-500)
Optimal working dilution should be determined by the investigator. -
Comment
-
Excitation / Emission wavelength: 743nm / 767nm
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 µg/µL
-
Buffer
- Aqueous buffered solution containing 100 µg/mL BSA, 50 % glycerol and 0.09 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Storage Comment
- Store at 4 °C for 12 months
-
Expiry Date
- 12 months
-
-
- CDKN2B (Cyclin-Dependent Kinase Inhibitor 2B (p15, Inhibits CDK4) (CDKN2B))
-
Alternative Name
- CDKN2B
-
Background
- P15 INK4b / MTS 2 (Mitotic Inhibitor / Suppressor Protein) is a specific inhibitor of cdk 4 / cdk 6 and is periodically expressed during the cell cycle. Reportedly, p15 INK4b expression is induced approximately 30 fold in human keratinocytes by treatment with TGF beta, suggesting that p15 INK4b may act as an effector of TGF beta mediated cell cycle arrest. p15 INK4b is mapped to chromosome 9p21, a region of frequent loss in a wide variety of cancers.
-
Molecular Weight
- 15kDa
-
Gene ID
- 1030
-
Pathways
- Cell Division Cycle, Mitotic G1-G1/S Phases
Target
-